Your browser doesn't support javascript.
loading
Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.
Palte, Rachel L; Juan, Veronica; Gomez-Llorente, Yacob; Bailly, Marc Andre; Chakravarthy, Kalyan; Chen, Xun; Cipriano, Daniel; Fayad, Ghassan N; Fayadat-Dilman, Laurence; Gathiaka, Symon; Greb, Heiko; Hall, Brian; Handa, Mas; Hsieh, Mark; Kofman, Esther; Lin, Heping; Miller, J Richard; Nguyen, Nhung; O'Neil, Jennifer; Shaheen, Hussam; Sterner, Eric; Strickland, Corey; Sun, Angie; Taremi, Shane; Scapin, Giovanna.
Affiliation
  • Palte RL; Department of Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA. rachel.kubiak@merck.com.
  • Juan V; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Gomez-Llorente Y; Department of Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ, USA.
  • Bailly MA; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Chakravarthy K; Department of Discovery Biology, Merck & Co., Inc., Boston, MA, USA.
  • Chen X; Ipsen Bioscience Inc., Cambridge, MA, USA.
  • Cipriano D; Department of Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ, USA.
  • Fayad GN; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Fayadat-Dilman L; Department of Preclinical Development, Merck & Co., Inc., Boston, MA, USA.
  • Gathiaka S; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Greb H; Department of Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA.
  • Hall B; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Handa M; Synthekine Inc., Menlo Park, CA, USA.
  • Hsieh M; Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA.
  • Kofman E; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Lin H; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Miller JR; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Nguyen N; Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA.
  • O'Neil J; Department of Discovery Biology, Merck & Co., Inc., Boston, MA, USA.
  • Shaheen H; Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA.
  • Sterner E; Department of Discovery Oncology, Merck & Co., Inc., Boston, MA, USA.
  • Strickland C; Xilio Therapeutics, Waltham, MA, USA.
  • Sun A; Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA.
  • Taremi S; Pandion Therapeutics, Cambridge, MA, USA.
  • Scapin G; Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA.
Commun Biol ; 4(1): 1310, 2021 Nov 15.
Article in En | MEDLINE | ID: mdl-34782734
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Commun Biol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Commun Biol Year: 2021 Type: Article Affiliation country: United States